Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
-
Shares outstanding
-
266,212,950
-
Total 13F shares
-
9,009,943
-
Share change
-
+8,859,443
-
Total reported value
-
$241,253,000
-
Price per share
-
$26.79
-
Number of holders
-
49
-
Value change
-
+$237,222,000
-
Number of buys
-
47
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q2 2018
As of 30 Jun 2018,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,009,943 shares.
The largest 10 holders included
Woodford Investment Management Ltd, Cormorant Asset Management, LP, Capital World Investors, Alphabet Inc., Artal Group S.A., PRICE T ROWE ASSOCIATES INC /MD/, FIL Ltd, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BAKER BROS. ADVISORS LP, and Partner Fund Management, L.P..
This page lists
49
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.